Microba Life Sciences (ASX:MAP) Accounts Receivable : A$12.41 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Microba Life Sciences's accounts receivables for the quarter that ended in Dec. 2023 was A$12.41 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Microba Life Sciences's Days Sales Outstanding for the quarter that ended in Dec. 2023 was 692.08.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Microba Life Sciences's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was A$0.05.

Microba Life Sciences Accounts Receivable Historical Data

The historical data trend for Microba Life Sciences's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences Accounts Receivable Chart

Microba Life Sciences Annual Data

Trend

Jun22

Jun23

Accounts Receivable

0.59

0.60

Microba Life Sciences Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Receivable	2.23	0.59	3.36	0.60	12.41

Microba Life Sciences Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Microba Life Sciences Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Microba Life Sciences's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	12.412	/	3.273	*	91
=	692.08

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Microba Life Sciences's accounts receivable are only considered to be worth 75% of book value:

Microba Life Sciences's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(28.051	+	0.75 * 12.412	+	0.5 * 2.057	-	15.988
-	0	-	0)	/	447.852
=	0.05

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Microba Life Sciences Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Microba Life Sciences's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Microba Life Sciences (ASX:MAP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000

Website

https://www.microba.com

Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.

Microba Life Sciences (ASX:MAP) Headlines

No Headlines